KazIOR
Interventional Surgery Service is an innovative unit specializing in minimally invasive methods for the diagnosis and treatment of malignant tumors. The center’s work is based on the principles of personalized medicine, a minimally invasive approach, and international standards of safety and efficacy.
Key Areas of Activity:
Radiofrequency and Microwave Ablation of tumors in the liver, thyroid, lungs, and kidneys.
Transarterial interventions: chemoembolization, embolization of metastases and tumor-feeding vessels.
Percutaneous biopsies and drainages under ultrasound and CT guidance.
Radiomic analysis and visual navigation using artificial intelligence for treatment efficacy assessment and recurrence prediction.
Central venous access for chemotherapy administration (implantation of subcutaneous port systems, PICC-line catheters)
Treatment is provided under the state-guaranteed medical care, compulsory social health insurance, and on a commercial basis.
Team-based approach: The service operates in a multidisciplinary tumor board format with participation of oncologic surgeons, radiologists, chemotherapists, and pathologists.
Objective: Development of personalized treatment strategies that combine minimal invasiveness with maximal oncologic radicality.
International Collaboration:
The center’s specialists regularly undergo training at leading clinics worldwide (USA, China, South Korea) and participate in international congresses such as CCMA, CIRSE, and ECIO.
The center actively implements international best practices and participates in multicenter clinical trials.
Equipment and Technologies:
